A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD®

This publication has 18 references indexed in Scilit:

• Pregnancy Outcomes From the Pregnancy Registry of a Human Papillomavirus Type6/11/16/18 Vaccine
  Obstetrics & Gynecology, 2009
• Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial
  The Lancet, 2009
• The Burden of Genital Warts: A Study of Nearly 70,000 Women from the General Female Population in the 4 Nordic Countries
  The Journal of Infectious Diseases, 2007
• Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
  New England Journal of Medicine, 2007
• Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
  New England Journal of Medicine, 2007
• Vaccine-induced pathogen strain replacement: what are the mechanisms?
  Journal of The Royal Society Interface, 2007
• Safety and Persistent Immunogenicity of a Quadrivalent Human Papillomavirus Types 6, 11, 16, 18 L1 Virus-Like Particle Vaccine in Preadolescents and Adolescents
  The Pediatric Infectious Disease Journal, 2007
• Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18
  Clinical and Vaccine Immunology, 2005
• A five‐year evaluation of reports of overdose with indinavir sulfate
  Pharmacoepidemiology and Drug Safety, 2003
• Sample preparation and PCR amplification from paraffin-embedded tissues.
  Genome Research, 1994